Telix Pharmaceuticals Ltd Revenue per Employee (TLX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Telix Pharmaceuticals Ltd  (NASDAQ: TLX)
 

Telix Pharmaceuticals Ltd's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 2.65% in the fourth quarter 2025, year on year to cumulative value of $803 million, Telix Pharmaceuticals Ltd's revenue per employee grew on a trailing twelve months basis to $ 717,355, this marks a new company high.
Within the Healthcare sector Telix Pharmaceuticals Ltd achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Telix Pharmaceuticals Ltd has 1,120 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TLX Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 2.65 % - - - -
Sales per Employee (TTM) $ 717,355 698,820 698,820 698,820 698,820
TLX's Total Ranking # # # # #
Seq. Revenue Change - - - - -

TLX Company Profile >> Back to TLX Efficiency Comparisons >> Compare TLX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 717,355 $ 717,355 $ 717,355
(Dec 31 2025)  



Financial Statements
Telix Pharmaceuticals Ltd's Revenue MRQ $ 803 Millions Visit TLX's Income Statement
Telix Pharmaceuticals Ltd's Revenues TTM $ 803 Millions Visit TLX's aggregate revenue growth
What are TLX's Sales? Visit TLX's Sales by Segment




Other Ratios
Telix Pharmaceuticals Ltd's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TLX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TLX's Competitors
Revenue per Employee for TLX's Suppliers
Revenue per Employee for TLX's Customers

You may also want to know
TLX's Sales Growth Rates TLX's Pe Price to earnings ratio TLX's Receivables Turnover Ratio TLX's Stock Quote
TLX's Net Income Growth Rates TLX's Ps Price to Sales ratio TLX's Sales per Employee TLX's Asset Turnover Ratio
TLX's Net Margin TLX's Pb Price to Book ratio TLX's Financial Strength Ratios TLX's Dividend Payout Ratio
Date modified: 2026-07-07T14:04:47+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Indivior Pharmaceuticals Inc   1,240,000.00 $ 1,240.000  Million 1,000 
Amicus Therapeutics inc   1,238,410.96 $ 632.828  Million 511 
Akebia Therapeutics Inc   1,217,505.15 $ 236.196  Million 194 
Heron Therapeutics Inc   1,207,476.56 $ 154.557  Million 128 
Theravance Biopharma inc   1,194,044.44 $ 107.464  Million 90 
Scynexis Inc   1,144,500.00 $ 20.601  Million 18 
Cytomx Therapeutics Inc   1,104,362.32 $ 76.201  Million 69 
Supernus Pharmaceuticals inc   1,102,687.12 $ 718.952  Million 652 
Stoke Therapeutics Inc   1,084,823.53 $ 184.420  Million 170 
Abbvie Inc   1,072,982.46 $ 61,160.000  Million 57,000 
Arvinas Inc   1,067,479.67 $ 262.600  Million 246 
Journey Medical Corp  1,066,517.24 $ 61.858  Million 58 
Arcutis Biotherapeutics Inc   1,062,350.28 $ 376.072  Million 354 
Madrigal Pharmaceuticals Inc   1,047,434.97 $ 958.403  Million 915 
Corcept Therapeutics Inc  1,043,023.29 $ 761.407  Million 730 
Integrated Biopharma Inc  1,021,360.00 $ 51.068  Million 50 
Biomarin Pharmaceutical Inc  1,000,078.55 $ 3,221.253  Million 3,221 
Coya Therapeutics Inc   993,219.13 $ 7.946  Million 8 
Assembly Biosciences Inc   990,452.05 $ 72.303  Million 73 
Travere Therapeutics Inc   987,380.28 $ 490.728  Million 497 
Hims and Hers Health Inc   961,252.25 $ 2,347.378  Million 2,442 
Sanara Medtech Inc   949,972.34 $ 102.597  Million 108 
Cue Biopharma Inc   947,103.45 $ 27.466  Million 29 
Lifevantage Corp  934,533.63 $ 208.401  Million 223 
Regeneron Pharmaceuticals Inc   930,752.76 $ 14,342.900  Million 15,410 
Ani Pharmaceuticals Inc  910,686.60 $ 883.366  Million 970 
Keenova Therapeutics Plc  906,562.50 $ 1,450.500  Million 1,600 
Scilex Holding Company  889,794.12 $ 30.253  Million 34 
Evolus Inc   889,541.92 $ 297.107  Million 334 
Day One Biopharmaceuticals Inc   888,662.92 $ 158.182  Million 178 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.